Treatment of Leber hereditary optic neuropathy

Brain

Volumn 134, Issue 9, 2011, Pages 2447-2450

  Newman, Nancy J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA TOCOPHEROL; APOPTOSIS INHIBITOR; ARGININE; ASCORBIC ACID; BRIMONIDINE PURITRE; CARNITINE; CREATINE; CYANOCOBALAMIN; CYCLOSPORIN A; DICHLOROACETIC ACID; FOLIC ACID; GLUTATHIONE; IDEBENONE; MENADIOL; MINOCYCLINE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RIBOFLAVIN; THIAMINE; THIOCTIC ACID; UBIDECARENONE; UNCLASSIFIED DRUG;

AGE; APOPTOSIS; CRANIOTOMY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG MEGADOSE; GENE THERAPY; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MULTICENTER STUDY (TOPIC); NERVE FIBER; NOTE; OPTIC DISK; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA GANGLION CELL; RETINA NERVE CELL; VISUAL ACUITY; VISUAL AID; VISUAL IMPAIRMENT;

EID: 80052935308     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr192     Document Type: Note

References (33)

1. Barboni P, Savini G, Valentino ML, La Morgia C, Bellusci C, De Negri AM, et al. Leber's hereditary optic neuropathy with childhood onset. Invest Ophthalmol Vis Sci 2006; 47: 5303-9. (Pubitemid 46723779)
2. Barboni P, Savini G, Valentino ML, Montagna P, Cortelli P, De Negri AM, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005; 112: 120-6. (Pubitemid 40075330)
3. Barnils N, Mesa E, Munoz S, Ferrer-Artola A, Arruga J. Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy. Arch Soc Esp Oftalmol 2007; 82: 377-80.
4. Carelli V, Barboni P, Zacchini A, Mancini R, Monari L, Cevoli S, et al. Leber's hereditary optic neuroapathy (LHON) with 14484/ND6 mutation in a North African patient. J Neurol Sci 1998; 160: 183-8. (Pubitemid 28522546)
5. Carelli V, La Morgia C, Valentino ML, Rizzo G, Carrbonelli M, De Negri AM, et al. Idebenone treatment in Leber's hereditary optic neuropathy. (Letter to the Editor) Brain (this issue) 2011.
6. Chinnery PF, Majaama K, Turnbull D, Thorburn D. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2006; 1: CD004426.
7. Cortelli P, Montagna P, Pierangeli G, Lodi R, Barboni P, Liguori R, et al. Clinical and brain bioenergetics improvement with idebenone in a patient with Leber hereditary optic neuropathy: a clinical and P-MRS study. J Neurol Sci 1997; 148: 25-31. (Pubitemid 27149521)
8. Craven L, Tuppen HA, Greggains GD, Harbottle SJ, Murphy JL, Cree LM, et al. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 2010; 465: 82-5.
9. DiMauro S, Mancuso M. Mitochondrial diseases: therapeutic approaches. Biosci Rep 2007; 27: 125-37. (Pubitemid 46940941)
10. Di Prospero NA, Baker A, Jeffries N, Fishbeck KH. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomized, placebo-controlled trial. Lancet Neurol 2007; 6: 878-86. (Pubitemid 47404985)
11. Fraser JA, Newman NJ, Biousse V. The Neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol 2010; 55: 299-334.
12. Imachi J. Neuro-surgical treatment of Leber's optic atrophy and its pathogenetic relationship to arachnoiditis. In: Brunette JR, Barbeau A, editors. Progress in ophthalmology (Proceedings of the Second Internation Congress of Neuro-Genetics and Neuro-Ophthalmology). Vol. 2. Amsterdam: Excerpta Medica; 1967. p. 121.
13. Imachi J, Nishizaki K. The patients of Leber's optic atrophy should be treated neuro-surgically. Nippon Ganka Kiyo Jpn 1970; 21: 209-17.
14. Kirkman M, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009; 132: 2317-26.
15. Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain (this issue) 2011.
16. Koilkonda RD, Guy J. Leber's hereditary optic neuropathy-gene therapy: from benchtop to bedside. J Ophthalmol 2011; 2011: 179412.
17. Lagedrost SJ, Sutton MS, Cohen MS, Satou GM, Kaufman BD, Perlman SL, et al. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). Am Heart J 2011; 161: 639-45.
18. Lynch DR, Perlman SL, Meier T. A phase 3, double-blind, placebo-controlled trial of idebenone in Friedreich ataxia. Arch Neurol 2010; 67: 941-7.
19. Mariotti C, Solari A, Torta D, Marano L, Fiorentini C, Di Donato S. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology 2003; 60: 1676-9. (Pubitemid 36618100)
20. Mashima Y, Hiida Y, Oguchi Y. Remission of Leber's hereditary optic neuropathy with idebenone. Lancet 1992; 340: 368-9.
21. Mashima Y, Kigasawa K, Wakakura M, Oguchi Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J Neuro-ophthalmol 2000; 20: 166-70.
22. Newman NJ. Hereditary optic neuropathies. In: Miller NR, Newman NJ, Biousse V, Kerrison JB, editors. Walsh & Hoyt's clinical neuro-ophthalmology. 6th edn. Baltimore: Williams & Willkins; 2005. p. 465-501.
23. Newman NJ. Leber hereditary optic neuropathy: bad habits, bad vision? Brain 2009; 132: 2306-8.
24. Newman NJ, Biousse V, David R, Bhatti MT, Hamilton SR, Farris BK, et al. Prophylaxis for second eye involvement in Leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am J Ophthalmol 2005; 140: 407-15.
25. Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 1991; 111: 750-62.
26. Oostra RJ, Bolhuis PA, Wijburg FA, Zorn-Ende G, Bleeker-Wagemakers EM. Leber's hereditary optic neuropathy: correlations between mitochondrial genotype and visual outcome. J Med Genet 1994; 31: 280-6. (Pubitemid 24127526)
27. Ramos Cdo V, Bellusci C, Savini G, Carbonelli M, Berezovsky A, Tamaki C, et al. Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2009; 50: 1666-74.
28. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995; 118: 319-37.
29. Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 2007; 35: 235-42.
30. Stone EM, Newman NJ, Miller NR, Johns DR, Lott MT, Wallace DC. Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. J Clin Neuro-ophthalmol 1992; 12: 10-4.
31. Tachibana M, Sparman M, Sritanaudomchai H, Ma H, Clepper L, Woodward J, et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009; 461: 367-72.
32. Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathy-disease mechanisms and therapeutic strategies. Prog Ret Eye Res 2011; 30: 81-114.
33. Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited optic neuropathies. J Med Genet 2009; 46: 145-58.